Clinical Trial Update: RegoNivo vs Standard of Care Chemotherapy in AGOC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing RegoNivo (regorafenib + nivolumab) against standard-of-care chemotherapy in gastroesophageal cancer; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Cancer

Drugs mentioned

• Regorafenib (regorafenib)
• nivolumab (nivolumab)

Snippet

Sponsor: Australasian Gastro-Intestinal Trials Group | Conditions: Gastro-Oesophageal Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING